[HTML][HTML] Effects of peroxisome proliferator-activated receptor γ and its ligand on blood–retinal barrier in a streptozotocin-induced diabetic model
K Muranaka, Y Yanagi, Y Tamaki, T Usui… - … & Visual Science, 2006 - arvojournals.org
purpose. To clarify whether endogenous peroxisome proliferator-activated receptor γ
(PPARγ) and its ligand, rosiglitazone, affect retinal leukostasis and the associated vascular …
(PPARγ) and its ligand, rosiglitazone, affect retinal leukostasis and the associated vascular …
[HTML][HTML] Effects of Peroxisome Proliferator-Activated Receptor γ and Its Ligand on Blood–Retinal Barrier in a Streptozotocin-Induced Diabetic Model
K Muranaka, Y Yanagi, Y Tamaki, T Usui… - … & Visual Science, 2006 - jov.arvojournals.org
purpose. To clarify whether endogenous peroxisome proliferator-activated receptor γ
(PPARγ) and its ligand, rosiglitazone, affect retinal leukostasis and the associated vascular …
(PPARγ) and its ligand, rosiglitazone, affect retinal leukostasis and the associated vascular …
[引用][C] Effects of Peroxisome Proliferator-Activated Receptor γ and Its Ligand on Blood–Retinal Barrier in a Streptozotocin-Induced Diabetic Model
K Muranaka, Y Yanagi, Y Tamaki, T Usui… - … Opthalmology & Visual …, 2006 - cir.nii.ac.jp
Effects of Peroxisome Proliferator-Activated Receptor γ and Its Ligand on Blood–Retinal Barrier in
a Streptozotocin-Induced Diabetic Model | CiNii Research CiNii 国立情報学研究所 学術情報 …
a Streptozotocin-Induced Diabetic Model | CiNii Research CiNii 国立情報学研究所 学術情報 …
Effects of peroxisome proliferator-activated receptor gamma and its ligand on blood-retinal barrier in a streptozotocin-induced diabetic model
K Muranaka, Y Yanagi, Y Tamaki… - … & visual science, 2006 - pubmed.ncbi.nlm.nih.gov
Purpose To clarify whether endogenous peroxisome proliferator-activated receptor gamma
(PPARgamma) and its ligand, rosiglitazone, affect retinal leukostasis and the associated …
(PPARgamma) and its ligand, rosiglitazone, affect retinal leukostasis and the associated …
[PDF][PDF] Effects of Peroxisome Proliferator-Activated Receptor and Its Ligand on Blood–Retinal Barrier in a Streptozotocin-Induced Diabetic Model
K Muranaka, Y Yanagi, Y Tamaki, T Usui… - … Ophthalmology & Visual …, 2006 - Citeseer
PURPOSE. To clarify whether endogenous peroxisome proliferator-activated
receptor(PPAR) and its ligand, rosiglitazone, affect retinal leukostasis and the associated …
receptor(PPAR) and its ligand, rosiglitazone, affect retinal leukostasis and the associated …
Effects of peroxisome proliferator-activated receptor gamma and its ligand on blood-retinal barrier in a streptozotocin-induced diabetic model.
K Muranaka, Y Yanagi, Y Tamaki, T Usui… - … & Visual Science, 2006 - europepmc.org
Purpose To clarify whether endogenous peroxisome proliferator-activated receptor gamma
(PPARgamma) and its ligand, rosiglitazone, affect retinal leukostasis and the associated …
(PPARgamma) and its ligand, rosiglitazone, affect retinal leukostasis and the associated …
[引用][C] Effects of peroxisome proliferator-activated receptor y and its ligand on blood-retinal barrier in a streptozotocin-induced diabetic model
K MURANAKA, Y YANAGI, Y TAMAKI… - … & visual science, 2006 - pascal-francis.inist.fr
Effects of peroxisome proliferator-activated receptor y and its ligand on blood-retinal barrier
in a streptozotocin-induced diabetic model CNRS Inist Pascal-Francis CNRS Pascal and …
in a streptozotocin-induced diabetic model CNRS Inist Pascal-Francis CNRS Pascal and …
[PDF][PDF] Effects of Peroxisome Proliferator-Activated Receptor and Its Ligand on Blood–Retinal Barrier in a Streptozotocin-Induced Diabetic Model
K Muranaka, Y Yanagi, Y Tamaki, T Usui… - … & Visual Science, 2006 - researchgate.net
PURPOSE. To clarify whether endogenous peroxisome proliferator-activated
receptor(PPAR) and its ligand, rosiglitazone, affect retinal leukostasis and the associated …
receptor(PPAR) and its ligand, rosiglitazone, affect retinal leukostasis and the associated …
[HTML][HTML] Effects of Peroxisome Proliferator-Activated Receptor γ and Its Ligand on Blood–Retinal Barrier in a Streptozotocin-Induced Diabetic Model
K Muranaka, Y Yanagi, Y Tamaki… - … & Visual Science, 2006 - iovs.arvojournals.org
purpose. To clarify whether endogenous peroxisome proliferator-activated receptor γ
(PPARγ) and its ligand, rosiglitazone, affect retinal leukostasis and the associated vascular …
(PPARγ) and its ligand, rosiglitazone, affect retinal leukostasis and the associated vascular …
[引用][C] Effects of peroxisome proliferator-activated receptor gamma and its ligand on blood-retinal barrier in a streptozotocin-induced diabetic model
K MURANAKA - Invest Ophthalmol Vis Sci, 2006 - cir.nii.ac.jp
Effects of peroxisome proliferator-activated receptor gamma and its ligand on blood-retinal
barrier in a streptozotocin-induced diabetic model | CiNii Research CiNii 国立情報学研究所 学術 …
barrier in a streptozotocin-induced diabetic model | CiNii Research CiNii 国立情報学研究所 学術 …